School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, Baltimore and Bethesda, Maryland, USA.
Alcohol Clin Exp Res. 2021 Nov;45(11):2207-2216. doi: 10.1111/acer.14719. Epub 2021 Sep 30.
Ghrelin may influence several alcohol-related behaviors in animals and humans by modulating central and/or peripheral biological pathways. The aim of this exploratory analysis was to investigate associations between ghrelin administration and the human circulating metabolome during alcohol exposure in nontreatment seeking, heavy drinking individuals with alcohol use disorder (AUD).
We used serum samples from a randomized, crossover, double-blind, placebo-controlled human laboratory study with intravenous (IV) ghrelin or placebo infusion in two experiments. During each session, participants received a loading dose (3 µg/kg) followed by continuous infusion (16.9 ng/kg/min) of acyl ghrelin or placebo. The first experiment included an IV alcohol self-administration (IV-ASA) session and the second experiment included an IV alcohol clamp (IV-AC) session, both with the counterbalanced infusion of ghrelin or placebo. Serum metabolite profiles were analyzed from repeated blood samples collected during each session.
In both experiments, ghrelin infusion was associated with an altered serum metabolite profile, including significantly increased levels of cortisol (IV-ASA q-value = 0.0003 and IV-AC q < 0.0001), corticosterone (IV-ASA q = 0.0202 and IV-AC q < 0.0001), and glycochenodeoxycholic acid (IV-ASA q = 0.0375 and IV-AC q = 0.0013). In the IV-ASA experiment, ghrelin infusion increased levels of cortisone (q = 0.0352) and fatty acids 18:1 (q = 0.0406) and 18:3 (q = 0.0320). Moreover, in the IV-AC experiment, ghrelin infusion significantly increased levels of glycocholic acid (q < 0.0001) and phenylalanine (q = 0.0458).
IV ghrelin infusion, combined with IV alcohol administration, was associated with increases in the circulating metabolite levels of corticosteroids and glycine-conjugated bile acids, among other changes. Further research is needed to understand the role that metabolomic changes play in the complex interaction between ghrelin and alcohol.
Ghrelin 可能通过调节中枢和/或外周生物途径来影响动物和人类的几种与酒精相关的行为。本探索性分析的目的是在非治疗性寻求、重度饮酒且患有酒精使用障碍(AUD)的个体中,研究在酒精暴露期间给予 ghrelin 与人类循环代谢组之间的关联。
我们使用了来自一项随机、交叉、双盲、安慰剂对照的人类实验室研究的血清样本,该研究在两项实验中静脉内(IV)给予 ghrelin 或安慰剂输注。在每次实验中,参与者接受 3 µg/kg 的负荷剂量(loading dose),然后连续输注(16.9ng/kg/min)酰化 ghrelin 或安慰剂。第一项实验包括 IV 酒精自我给药(IV-ASA)实验,第二项实验包括 IV 酒精钳夹(IV-AC)实验,两项实验均以 ghrelin 或安慰剂的平衡输注进行。从每次实验中重复采集的血液样本中分析血清代谢物谱。
在两项实验中,ghrelin 输注与血清代谢物谱的改变有关,包括皮质醇(IV-ASA q 值 = 0.0003 和 IV-AC q < 0.0001)、皮质酮(IV-ASA q 值 = 0.0202 和 IV-AC q < 0.0001)和甘氨脱氧胆酸(IV-ASA q 值 = 0.0375 和 IV-AC q 值 = 0.0013)水平显著升高。在 IV-ASA 实验中,ghrelin 输注增加了皮质酮(q 值 = 0.0352)和脂肪酸 18:1(q 值 = 0.0406)和 18:3(q 值 = 0.0320)的水平。此外,在 IV-AC 实验中,ghrelin 输注显著增加了甘胆酸(q < 0.0001)和苯丙氨酸(q 值 = 0.0458)的水平。
IV ghrelin 输注与 IV 酒精给药相结合,与皮质类固醇和甘氨酸结合胆汁酸等循环代谢物水平的升高有关。需要进一步的研究来了解代谢组学变化在 ghrelin 与酒精之间复杂相互作用中所起的作用。